Methazel (Sterling-Knight Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Methazel drug offered from Sterling-Knight Pharmaceuticals, LLC. This Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sterling-Knight Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | Methazel |
| SUBSTANCE NAME: | FOLIC ACID; PYRIDOXAL 5-PHOSPHATE; METHYLCOBALAMIN; COENZYME Q10, (2Z)-; ALPHA LIPOIC ACID; ACETYLCYSTEINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2015-10-12 |
| END MARKETING DATE: | 0000-00-00 |
Methazel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Methazel from Sterling-Knight Pharmaceuticals, LLC |
| LABELER NAME: | Sterling-Knight Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; 50; 2.5; 25; 50; 50(mg/1; mg/1; mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2015-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69336-350_9b74d855-bc07-4fa4-b48d-aafdff54343d |
| PRODUCT NDC: | 69336-350 |
| APPLICATION NUMBER: | |
Other FOLIC ACID; PYRIDOXAL 5-PHOSPHATE; METHYLCOBALAMIN; COENZYME Q10, (2Z)-; ALPHA LIPOIC ACID; ACETYLCYSTEINE Pharmaceutical Manufacturers / Labelers:
